2020-2027 Analysis and Review Allergen Immunotherapy Market

Allergen Immunotherapy Market

Allergen Immunotherapy Market By Treatment (Subcutaneous Immunotherapy and Sublingual Immunotherapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

22-05-2020 REP-HC-5093 40 Tables 120 pages Format

The Allergen immunotherapy market was valued at USD 1,303.5 Mn by 2019. As per the latest statistics provided by the World Health Organization (WHO), approximately 57% of the adult patients suffering from allergic rhinitis have sleeping problems, fatigue, and decreased cognitive function. Promising product pipeline for the treatment of allergic reactions will further propel the market growth.

Allergen Immunotherapy Market

Allergen immunotherapy is considered an important treatment regimen for the management of allergic reactions as researchers have opined that only pharmacological therapy is not sufficient, proper emphasis needs to be put on building the immunity against various allergens for maximum long term benefit.

The major segments related to the allergen immunotherapy market are: 

By Treatment (2017–2027; US$ Mn)

Subcutaneous Immunotherapy

Sublingual Immunotherapy

Others

By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global allergen immunotherapy market
  • The overall segmentation of the allergen immunotherapy market, by treatment, distribution channel, and geography is minutely studied. Subcutaneous immunotherapy and hospital pharmacy are dominating the treatment and distribution channel segments respectively
  • Rising prevalence of allergic reactions worldwide
  • Significant increase in the research and development activities pertaining to the development of allergic immunotherapy and promising product pipeline further drive the market growth

Report gist?

The study of the global allergen immunotherapy market includes qualitative analysis of factors such as drivers, restraints, and opportunities

The report covers the qualitative and quantitative analysis of the overall market segmented on the basis of treatment and distribution channel and categorization of the same at the geography level

This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the biopharmaceutical companies actively engaged in the production and marketing of allergen immunotherapy due to the  rising prevalence of allergic infections worldwide
  • The report will benefit researchers engaged in the development of promising product pipeline in the allergic immunotherapy market
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to allergen immunotherapy market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Subcutaneous immunotherapy is spearheading the treatment segment for allergy immunotherapy market. The ergonomic features associate with subcutaneous immunotherapy is its ability to provide high therapeutic efficacy in cases of respiratory allergies, it is administered in simple and standard dosage doses which is beneficial in providing long term symptomatic relief in allergic reactions. Patients need to be monitored for at least 30 minutes post-injection. Immunomodulation by subcutaneous injection occurs via a buildup phase which ranges from 3 to 6 months and then the maintenance phase which ranges from 2 to 4 weeks. Sublingual immunotherapy is anticipated to register sturdy market growth during the forecast period on account of its enhanced therapeutic efficacy for seasonal allergies. Technological advancement in the development of sublingual tablets for the treatment of dust, ragweed, and pollen allergies will further accentuate its market growth.

Hospital pharmacy is presently dominating the distribution channel segment for the Allergen Immunotherapy market. Drug posology is a critical phenomenon related to allergic immunotherapy, thus it is necessary for accurate compounding of allergic immunotherapy drugs by the hospital pharmacist to prevent any fatal health effects associated with non-compliance with a physician's prescriptions. Retail pharmacy is expected to grow at a rapid pace in the near future on account of the availability of medicines at government-sponsored subsidized rates and cater medical requirements of patients residing in remote locations.

Europe is presently leading the geography segment for allergy immunotherapy market. The rising prevalence of seasonal rhinitis primarily drives market growth in the region. As per the latest research citings provided by the European Academy of Allergy and Clinical Immunology (EAACI), approximately 20% of the European population suffer from season allergy and constant fear of a possible anaphylactic shock reaction, asthma attack or even death from an allergic attack. Affordable reimbursement scenario for the allergic immunotherapy further drives the market growth in the region. North America is the second-largest regional segment in the allergic immunotherapy market. The supportive regulatory environment provided by the USFDA for the growth of allergen immunotherapy drives the market growth in the region. Asia Pacific is anticipated to register the fastest market growth in the regional segment. Growing industrialization has given rise to the occurrence of allergic reactions due to house dust mites, air pollutions, pollen grains, etc. Rising public health awareness regarding the benefits of allergic immunotherapy will further accentuate the market growth in the region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.